Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.08 -0.03 (-1.66%)
As of: Oct 22, 2026 · 3:59 PM EDT

Ernexa Therapeutics (ERNA) Debt Ratio (2013 - 2025)

Updated

Ernexa Therapeutics' Debt Ratio came in at 0.44 for Q1 2025.

Analysis

Ernexa Therapeutics (ERNA) Debt Ratio (2013 - 2025) Analysis & Trends

For FY2020, Ernexa Therapeutics' Debt Ratio was 0.07, down 62.4% from FY2019.

  • Debt Ratio has declined in each of the last four years.
  • Going back by year, Debt Ratio was 0.19 in FY2019 (-22.7%), 0.25 in FY2018 (-18.0%), 0.31 in FY2017 (-37.1%) and 0.49 in FY2016 (+7.2%).
  • The Q1 2025 figure represents the highest quarterly Debt Ratio since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Ernexa Therapeutics 2.45 Mn -16.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 0.44
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.02
Dec 31, 2020 0.07
Sep 30, 2020 0.66
Mar 31, 2020 0.18
Dec 31, 2019 0.19
Sep 30, 2019 0.20
Jun 30, 2019 0.21
Mar 31, 2019 0.21
Dec 31, 2018 0.25
Jun 30, 2018 0.29
Mar 31, 2018 0.31
Dec 31, 2017 0.31
Sep 30, 2017 0.30
Jun 30, 2017 0.29
Mar 31, 2017 0.44
Dec 31, 2016 0.49
Sep 30, 2016 0.55
API Access

Ernexa Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=ERNA&period=max&api_key=YOUR_API_KEY